The cytotoxicity of the clinically important antineoplastic quinones doxorubicin, mitomycin C, and diaziridinylbenzoquinone for the Ehrlich ascites carcinoma was significantly reduced or abolished by the antioxidant enzymes catalase and superoxide dismutase, the hydroxyl radical scavengers dimethyl sulfoxide, diethylurea, and thiourea, and the iron chelators deferoxamine, 2,2-bipyridine, and diethylenetriaminepentaacetic acid. However, tumor cell killing by 5-iminodaunorubicin, a doxorubicin analog with a modified quinone function that prohibits oxidation-reduction cycling, was not ameliorated by any of the free radical scavengers tested. Furthermore, treatment of intact tumor cells with doxorubicin, mitomycin C, and diaziridinylbenzoquinone but not 5-iminodaunorubicin generated the hydroxyl radical, or a related chemical oxidant, in vitro in a process that required hydrogen peroxide, iron, and intact tumor cells. These results suggest that drug-induced hydrogen peroxide and hydroxyl radical production may play a role in the antineoplastic action of redox active anticancer quinones.
Quinone-containing antineoplastic agents, including doxorubicin (DOX), mitomycin C (MMC), and diaziridinylbenzoquinone (AZQ), constitute one of the most important groups of chemicals used in cancer chemotherapy because they possess significant therapeutic action in the treatment of most hematologic malignancies as well as carcinomas of the lung, breast, ovary, brain, and gastrointestinal tract (1) (2) (3) . Although the mechanism of tumor cell killing by these drugs has been related to their effects on DNA structure or synthesis as a consequence of intercalation or alkylation (2) (3) (4) , recent evidence suggests that cytotoxicity, at least for DOX, may also be due to lethal events occurring at extranuclear sites (5, 6) . Furthermore, despite studies demonstrating reactive oxygen production and DNA damage after cyclical reduction and oxidation of the quinone function in the presence of purified NADPH-cytochrome P-450 reductase (7), NADH dehydrogenase (8) , and xanthine oxidase (9, 10) , conclusive evidence regarding a role of the quinone moiety in the anticancer action of these compounds for intact cells is lacking.
Quite recently, however, production of potent oxidizing species, including the hydroxyl radical ( OH), has been demonstrated during treatment of intact human MCF-7 breast cancer cells with DOX (11) . Furthermore, resistance to the cytotoxic effect of DOX in this cell line apparently involves, at least in part, a significant enhancement of intracellular antioxidant defense enzymes (12) . These preliminary results, taken together with studies from this laboratory indicating that DOX, MMC, and AZQ stimulate superoxide anion and H202 production by microsomal, mitochondrial, and nuclear preparations from Ehrlich tumor cells, strongly suggest that oxygen radical metabolism might play a role in the antineoplastic action of the anticancer quinones (13) (14) (15) .
For these reasons, the effect of a wide range of reactive oxygen scavengers on the toxicity of the major antineoplastic quinones for Ehrlich carcinoma cells was examined. Agents that detoxify H202 or *OH, including proteins that do not penetrate the cell surface, significantly reduced or abolished the cytotoxicity of these drugs. Thus, both extracellular and intracellular oxygen radical attack could be involved in the tumor cell toxicity produced by anticancer quinones. In addition, tumor cell killing was diminished by antioxidants only for drugs that generated reactive oxygen species from intact cells, suggesting that cytotoxicity from H202 or * OH is a specific explanation for at least part of the antineoplastic effect of these chemotherapeutic agents. The data for this study have been published in abstract form (46, 47 (36 ul) volume of drug for 1 hr; treatment of the cells with either the anticancer agent or a free radical scavenging agent or both always occurred in a total volume of 35 ml of DME medium/F12 medium/FCS. Briefly, 3 days after plating, paired groups of Ehrlich tumor cells in suspension culture (1-2 x 106 cells per ml) exponentially growing in DME medium/F12 medium/FCS were treated with either DME medium/F12 medium/FCS (10 ml) or an equal volume of medium with the scavenger under investigation for 1 hr; cells were then exposed to either 36 ,ul of medium or to an equal volume of the anticancer quinone for 1 hr. At the completion of drug exposure, cells were washed twice in fresh medium and resuspended in 5 ml of DME medium/F12 medium/FCS. The Ehrlich cells were counted in a hemocytometer and cell viability (in all cases >95%) was measured by trypan blue dye exclusion.
Cell survival after drug treatment for the tumor cells was then determined by soft agar cloning as described (21) . Dilutions of 1000 and 10,000 cells were prepared in the resuspension medium and plated in triplicate in 35 x 10 and 60 x 15 mm Petri dishes, respectively. For these studies, the feeder layer consisted of DME medium/F12 medium/FCS and 0.5% agar; the overlayer contained the cells, DME medium/F12 medium/FCS, and 0.3% agarose. Colonies of >50 cells were counted 6 days after plating. The percentage of clonogenic cell survival has been expressed as the number of colonies produced by drug-treated cells divided by the number of colonies produced by control cells (corrected for cloning efficiency) x 100. The plating or cloning efficiency of the Ehrlich cells in this system [which is defined as the ratio of the number of colonies counted divided by the number of cells initially plated (22) ] ranged from 40% to 75%. Detailed control experiments revealed that in the concentrations used for these studies none of the free radical scavenging agents produced any significant effect on the plating efficiency of the tumor cells.
Measurement of * OH Production. The formation of * OH, or an oxidizing species with the chemical reactivity of * OH, by
Ehrlich tumor cells treated with anticancer quinones was assessed by measurement of CH4 production from Me2SO by using a modification of the method of Repine et al. (23, 24) as published recently (8) . For these experiments, the 2-ml mixtures contained 2 x 107 tumor cells and 100 mM Me2SO
in DME medium/F12 medium/FCS, and the concentrations of reactive oxygen scavengers and anticancer quinones shown in Table 3 ; reactions were initiated by addition of the anticancer quinone into the gas-tight, siliconized reaction vessels by injection through the red rubber stopper. Incubation at 37°C was for 2 hr in a shaking water bath and reactions were terminated by placing the experimental tubes on melted ice. A 500-,lI sample of the headspace gas from each tube (total volume, 1 ml) was assayed for methane concentration. Statistical Analyses. Data were analyzed with the two-tailed Student's t test for independent means [not significant, P > 0.05 (25) ]. Data have been expressed as the mean ± 1 SEM.
RESULTS

Effect of Radical Scavengers and Antioxidant Enzymes on
Anticancer Quinone Cytotoxicity. The initial experiments investigated whether several potent OH scavengers altered the cytotoxicity of various antineoplastic quinones (Table 1) . Diethylurea, thiourea, and Me2SO significantly inhibited tumor cell killing by MMC, AZQ, and DOX; although thiourea was the most potent inhibitor of cytotoxicity, Me2SO produced complete protection against cell killing by DOX at a concentration of 300 mM, and diethylurea produced almost total protection for cells treated with DOX or MMC. It is important to point out that Me2SO, itself, may produce many biophysical changes in tumor cells in addition to scavenging *OH and that these effects might make cells was reconstituted in a 20% (vol/vol) dimethylacetamide stock solution; when used for these experiments, the final concentration of dimethylacetamide was never above 0.02% (vol/vol), which had no effect on tumor cloning efficiency. All reactive oxygen scavengers were prepared in tissue culture medium except PZ 51, which was initially dissolved in concentrated form in 100% (vol/vol) Me2SO; in these experiments, the final concentration of Me2SO, when used with PZ 51 was 5 mM, which was below the protective threshold for this agent. Results represent the mean ± SEM of three to six experiments for each drug with every scavenger; significance was determined by using the two-tailed t test for independent means. P values are indicated for the comparison between clonogenic cell survival after treatment with the anticancer quinone in the presence and the absence of a reactive oxygen scavenger. Conc., concentration; U, units. *Catalase and SOD were heat-inactivated (HI) by autoclaving for 60 min. tP < 0.05. tP < 0.02. §p < 0.01.
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Medical Sciences: Doroshow more resistant to DOX toxicity (26) . However, recent investigations have demonstrated no amelioration of DNA strand breakage by Me2SO in cells exposed to DOX (27) . Furthermore, urea, a structural analog of thiourea and diethylurea that is an ineffective -OH trapping agent (23), produced no significant effect on anticancer quinone cytotoxicity. These results, taken together, support the hypothesis that *OH formation contributed to Ehrlich tumor cell killing in the above experiments. Catalase and SOD, scavengers of H202 and superoxide anion, respectively, significantly inhibited tumor cell killing; since the heat-denatured proteins were not protective, it is unlikely that these results were simply due to a nonspecific protein effect or to alterations in drug uptake by the antioxidant enzymes. Furthermore, over a wide range of drug concentrations, catalase significantly inhibited tumor cell killing for MMC, AZQ, and DOX (Fig. 1) . It is of some interest that the drug concentrations found to inhibit clonogenic cell survival by 50% (IC50; Table 1 ) approximate quite closely the peak plasma concentrations of these agents after i.v. administration in man (1-3, 28, 29) . At the IC50 or lower, catalase produced substantial protection against cell killing; at higher drug concentrations, the extracellular antioxidant enzyme inhibited cytotoxicity to a lesser, albeit significant, extent (Fig. 1) . Inhibition of drug-related cytotoxicity by catalase occurred even though no evidence was found for the uptake of catalase into Ehrlich tumor cells in these experiments (data not shown). These studies suggest that the anticancer quinones may kill tumor cells by multiple mechanisms; however, H202-mediated events could predominate at lower drug concentrations.
As shown in Table 1 , PZ 51, a lipophilic organoselenium compound that possesses glutathione peroxidase-like activity for intact cells and that can effectively detoxify H202 in the presence of glutathione (17, 18) , significantly reduced the cytotoxicity of the anticancer quinones for Ehrlich cells. As a cytoprotective agent, PZ 51 was superior to catalase with respect to cell killing by DOX and AZQ.
In addition to scavengers of OH and H202, three iron chelating agents were examined to determine whether they could affect tumor cell killing by anticancer quinones (Table  2) . Each of these agents complexes iron in a form that is unavailable for participation in reactions generating * OH (30, 31) ; however, DTPA is incapable of penetrating the cell surface (32) , bipyridine enters cells freely (31) , and deferoxamine enters only certain mammalian cells but is capable of associating closely with the plasma membrane (33) (34) (35) . Deferoxamine and bipyridine reduced the toxicity of MMC, 62 ± 2* 62 ± lt These experiments were performed as described in the legend to Table 1 ; results represent the mean ± SEM of three to six experiments for each drug with every iron chelating agent. P values are indicated for the comparison between clonogenic cell survival after treatment with the anticancer quinone in the presence and the absence of an iron chelating agent. Conc., concentration. *P < 0.05. tP < 0.01. AZQ, and DOX, whereas DTPA did not reduce Ehrlich tumor cell killing by AZQ ( Table 2 ). These experiments suggest that the site of interaction between iron and the anticancer quinone (intracellular, extracellular, or cell membrane) may vary from drug to drug. However, since the level of iron in the tissue culture media (4 kkM), which could also be present in vivo under certain conditions (36) , has been demonstrated to be sufficient to catalyze * OH production in the presence of H202 (36), these experiments support the premise that iron-related reactive oxygen metabolism may be involved in tumor killing by anticancer quinones. Finally, none of the -OH scavengers, antioxidant enzymes, or iron chelators tested in Tables 1 and 2 produced any significant effect on the cytotoxicity of 5-iminodaunorubicin (IC50 = 4 MtM), an anthracycline analog that does not generate free radicals (data not shown). Further, the cytotoxicity of AZQ was not inhibited by SOD (Table 1) . Thus, the antioxidant proteins and chemicals used in this study did not produce a general, nonspecific inhibition of drug-related tumor cell killing in these experiments.
Effect (23, 24) ], it was found that the agents capable of inhibiting tumor cell killing by anticancer quinones significantly decreased -OH production by intact, drug-treated cells (Table 3) . Overall, thiourea was the most powerful inhibitor studied; this may be explained by the ability of this compound to react with and detoxify H202 and -OH (37) . In these experiments, no -OH was detected in the absence of an anticancer quinone; -OH production was abolished similarly by heat-denaturation of the carcinoma cells (Table 3) . Hydroxyl radical production was studied using drug concentrations substantially higher than those employed for cytotoxicity experiments. This was necessary in large part because the detecting system used here for OH is relatively inefficient. As shown (8) , only about 1% of the superoxide anion formation from oxidationreduction cycling of anticancer quinones results in the production of CH4 from Me2SO. The limited yield of CH4 is probably due to various factors, which include the multiple reaction products of Me2SO with the * OH and the possibility that CH4 produced intracellularly may only imperfectly traverse the plasma membrane (38) .
Tumor cells treated with 5-iminodaunorubicin (250 AuM; n = 4) produced no detectable methane from Me2SO (data not shown). These experiments, as well as the cytotoxicity studies with 5-iminodaunorubicin, are in agreement with recent investigations that have demonstrated that the iminosubstitution on the daunorubicin quinone effectively eliminates superoxide anion or H202 production by this compound after reaction with NADPH-cytochrome P-450 reductase (7) or NADH dehydrogenase (8) . It is noteworthy that the IC50 for 5-iminodaunorubicin (4 ,M) was nearly 3-fold higher than that for DOX; the IC50 for daunorubicin, itself, against Ehrlich tumor cells in this laboratory is 0.5-1.0 ,M. Since 5-iminodaunorubicin does not appear to produce oxygen free radicals in Ehrlich cells, the 4-to 8-fold difference in IC50 between daunorubicin and the analog might represent a free radical component involved in tumor cell killing by the parent anthracycline.
In related experiments, -OH production by whole tumor cells treated with AZQ did not appear to involve the superoxide anion because SOD produced no significant inhibition of methane formation from Me2SO (Table 3) . Recent studies by Szmigiero and colleagues (39) support the concept that (5, 6) , could also involve H202 or superoxide anion produced at or near the tumor cell surface as well as intracellularly.
The mechanism of * OH production by anticancer quinones has not been addressed directly in these studies. Prior investigations, however, suggest that cyclical reduction and oxidation of the quinone moiety of these drugs is involved in providing sufficient H202 for *OH production to proceed (7) (8) (9) (10) . In fact, the precise chemical pathway of * OH formation may differ between the drugs investigated in these experiments. However, *OH production in each case appeared to involve the interaction of an iron catalyst with H202. The source and biochemical form of the iron involved in these experiments is still a matter of conjecture. Recent studies have shown that Ehrlich cells contain =100 ,uM iron that is essentially all in protein-bound form (32 Whatever the precise mechanism involved, the oxidizing power of the * OH radical (43) could exert a powerful oxidant stress at multiple cellular sites in tumors treated with quinone-containing antineoplastic drugs. The potentially lethal events that could be produced by H202 or * OH in tumor cells are numerous but include deleterious effects on cellular calcium hemeostasis (44) and energy production (45) as well as diminished reproductive potential (31) .
The real possibility that oxygen free radicals are involved in the therapeutic action of the anticancer quinones MMC, AZQ, and DOX suggests, finally, that strategies aimed at altering the defenses of the tumor cell against oxidation may be a novel method of enhancing the effectiveness as well as the spectrum of activity for this widely used class of antineoplastic compounds.
